A carregar...
Bone Health in Patients with Breast Cancer: Recommendations from an Evidence-Based Canadian Guideline
Bone loss is common in patients with breast cancer. Bone modifying agents (BMAs), such as bisphosphonates and denosumab, have been shown to reverse or stabilize bone loss and may be useful in the primary and metastatic settings. The purpose of this review is to provide clear evidence-based strategie...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4470150/ https://ncbi.nlm.nih.gov/pubmed/26237149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm2040283 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|